World-first treatment for functional seizures
People living with functional seizures may soon have options to self-treat, thanks to a world-first, online digital treatment tool developed by clinician-researchers at The Alfred.
A randomised clinical trial of RePROGRAM, a self-guided series of online modules, found it was effective at reducing participants’ rate of functional seizures by 65 per cent.
Neuropsychologist Dr Lana Higson led the development of the program and trial, and said the results, published in JAMA, had big implications for the future of functional seizure treatments and accessibility.
“The exciting thing about this latest model is that it is easily scalable, replicable and has the potential to reach people who otherwise might not be able to access treatment,” Dr Higson said.
Functional seizures make up 20-25 per cent of referrals to specialist clinics in Australia. Roughly three out of four patients are women, with most experiencing functional seizures in their late teens to 30s.
"Unlike epilepsy, functional seizures are not caused by abnormal electrical activity in the brain," Dr Higson said.
“Instead, the latest research suggests they are a temporary miscommunication in the brain's networks; a functional issue than a structural one.
"This means that treatments that work for epilepsy such as prescription medication or surgery do not work for functional seizures, which require a totally different approach."
Designed to be completed over a period of weeks, Re-PROGRAM draws on biopsychosocial approaches to seizure management.
“We built the program around what people with functional seizures told us was helpful, combining evidence-based psychological approaches with emerging neurobiological understandings of the condition,” Dr Higson said.
“Our goal was to create a bridge between diagnosis and specialist treatment, so people could access support immediately rather than waiting months or years for care.”
Currently The Alfred's Functional Seizures Clinic is Australia's only publicly-accessible outpatient clinic providing specialist care for functional seizures.
Wait times for specialists, even at private clinics, tend to be very long.
“In Australia there are enormous barriers to accessing treatment. People may be unable to drive, face long waiting lists and struggle to find clinicians with expertise in functional seizures,” Dr Higson said.
“Having a program that people can access wherever they live gives them a place to start while they wait for specialist care.”